Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
AUSTIN, Texas, June 09, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...
In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival (PFS) was 16.6 months, compared ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email